KymaThera is a discovery-stage biotechnology company developing best-in-class medicines for serious diseases. KymaThera’s leadership team brings decades of experience advancing small-molecule therapeutics from concept to clinic, with a record of success spanning multiple therapeutic areas and dozens of development candidates and approved medicines.
KymaThera values collaboration across science, strategy, and innovation. If you’re interested in contributing to our mission or exploring partnership opportunities, reach out to our team.
